Literature DB >> 11748903

Inductive reasoning in Alzheimer's disease.

E E Smith1, J Rhee, K Dennis, M Grossman.   

Abstract

We evaluated knowledge of basic level and superordinate semantic relations and the role of cognitive resources during inductive reasoning in probable Alzheimer's disease (AD). Nineteen mildly demented AD patients and 17 healthy control subjects judged the truthfulness of arguments with a premise and a conclusion that contain familiar concepts coupled with "blank" predicates, such as "Spiders contain phosphatidylcholine; therefore all insects contain phosphatidylcholine." Like healthy control subjects, AD patients were relatively insensitive to the typicality of the premise category when judging the strength of arguments with a conclusion containing a basic-level concept, but were relatively sensitive to typicality during judgments of arguments containing a superordinate in the conclusion. Moreover, AD patients resembled control subjects in judging arguments with an immediate superordinate in the conclusion compared to arguments with a distant superordinate. AD patients differed from control subjects because they could not take advantage of two premises in an argument containing basic-level concepts. We conclude that semantic knowledge is sufficiently preserved in AD to support inductive reasoning, but that limited cognitive resources may interfere with AD patients' ability to consider the entire spectrum of information available during semantic challenges. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Year:  2001        PMID: 11748903     DOI: 10.1006/brcg.2001.1327

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  2 in total

1.  What is typical about the typicality effect in category-based induction?

Authors:  Jonathan R Rein; Micah B Goldwater; Arthur B Markman
Journal:  Mem Cognit       Date:  2010-04

2.  Knowledge of natural kinds in semantic dementia and Alzheimer's disease.

Authors:  Katy Cross; Edward E Smith; Murray Grossman
Journal:  Brain Lang       Date:  2008-03-04       Impact factor: 2.381

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.